The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1322
October 5, 2009
View Complete Issue         Table of Contents 2019 
H1N1 Vaccine for Prevention of Pandemic Influenza
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
H1N1 Vaccine for Prevention of Pandemic Influenza
October 5, 2009 (Issue: 1322)
The FDA has licensed 4 new monovalent vaccines for prevention of respiratory illness caused by a new influenza A H1N1 virus that appears to be derived from a swine strain. The 5th vaccine should be licensed soon. All of these vaccines are expected to...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: H1N1 Vaccine for Prevention of Pandemic Influenza
Article code: 1322a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.